SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
SEC File Number 0-24541
CUSIP Number 218724-10-2
NOTIFICATION OF LATE FILING
(Check one):
[X] Form 10-KSB [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR
For Period Ended: June 30, 2000
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: N/A
PART I. - Registrant Information
Full Name of Registrant CORGENIX MEDICAL
CORPORATION
Former Name if Applicable N/A
Address of Principal Executive Office
(Street and Number)
12061 Tejon Street
City, State and Zip Code
Westminster, CO 80234
September 29, 2000
<PAGE>
PART II. - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual or semiannual report/portion thereof will
be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report/portion
thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
[X] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
III. - Narrative
State in reasonable detail the reasons why the Form 10-KSB, 11-K, 20-F,
10-Q or N-SAR or portion thereof could not be filed within the
prescribed time period.
The Company's independent accountants have not completed their audit
for the fiscal year ended June 30, 2000.
IV. - Other Information
(1) Name and telephone number of person to contact in regard to this
notification.
(Name) (Area Code) (Telephone No.)
Douglass T. Simpson (303) 457-4345
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such reports been filed? If answer no, identify report(s).
[X] Yes [ ] No
September 29, 2000
-2-
<PAGE>
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the
subject report or portion thereof?
[ ] Yes [X] No
If so: Attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
Corgenix Medical Corporation
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: September 29, 2000 By: /s/ Douglass T. Simpson
------------------------------
Name: Douglass T. Simpson
Title: President
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
September 29, 2000
-3-
<PAGE>
We completed audit field work September 26, 2000 and are in the process of
integrating the audit results into the 10-KSB of Corgenix for its year ended
June 30, 2000.
KPMG LLP
Denver, Colorado
September 29, 2000
